Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes

Lipids in Health and Disease

Volumn 4, Issue , 2005, Pages

  Wilsie, Larissa C ^a   Chanchani, Shree ^a   Navaratna, Deepti ^a   Orlando, Robert A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHONDROITIN SULFATE; HEPARAN; LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURFACE; LIGAND BINDING; LIPID STORAGE; MOLECULAR WEIGHT; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; APOLIPOPROTEINS E; CELL DIFFERENTIATION; CELL MEMBRANE; GENE EXPRESSION REGULATION; HEPARAN SULFATE PROTEOGLYCANS; LDL-RECEPTOR RELATED PROTEINS; LIPID METABOLISM; MICE; MOLECULAR WEIGHT; RECEPTORS, LDL;

EID: 14544298806     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-4-2     Document Type: Article

References (78)

1. Attele AS, Shi ZQ, Yuan CS: Leptin, gut, and food intake. Biochemical Pharmacology 2002, 63(9):1579-1583.
2. Mohamed-Ali V, Pinkney JH, Coppack SW: Adipose tissue as an endocrine and paracrine organ. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 1998, 22(12):1145-1158.
3. Luxon BA, Milliano MT: Cytoplasmic transport of fatty acids in rat enterocytes: role of binding to fatty acid-binding protein. American Journal of Physiology 1999, 277(2 Pt 1):G361-6.
4. Storch J, Thumser AE: The fatty acid transport function of fatty acid-binding proteins. Biochimica et Biophysica Acta 2000, 1486(1):28-44.
5. Liu P, Ying Y, Zhao Y, Mundy DI, Zhu M, Anderson RG: Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. Journal of Biological Chemistry 2004, 279(5):3787-3792.
6. Hamilton JA: Transport of fatty acids across membranes by the diffusion mechanism. Prostaglandins Leukotrienes & Essential Fatty Acids 1999, 60(5-6):291-297.
7. Hamilton JA, Johnson RA, Corkey B, Kamp F: Fatty acid transport: the diffusion mechanism in model and biological membranes. Journal of Molecular Neuroscience 2001, 16(2-3):99-108; discussion 151-7.
8. Glatz JF, Luiken JJ, Bonen A: Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. Journal of Molecular Neuroscience 2001, 16(2-3):123-32; discussion 151-7.
9. Hajri T, Abumrad NA: Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annual Review of Nutrition 2002, 22:383-415.
10. Berk PD, Stump DD: Mechanisms of cellular uptake of long chain free fatty acids. Mol Cell Biochem 1999, 192(1-2):17-31.
11. Reuter SF, Prairie RL, Kaneshiro ES: The kinetics of fatty acid uptake by Paramecium tetraurelia. Journal of Eukaryotic Microbiology 1993, 40(3):370-376.
12. Zucker SD: Kinetic model of protein-mediated ligand transport: influence of soluble binding proteins on the intermembrane diffusion of a fluorescent fatty acid. Biochemistry 2001, 40(4):977-986.
13. Abumrad N, Harmon C, Ibrahimi A: Membrane transport of longchain fatty acids: evidence for a facilitated process. Journal of Lipid Research 1998, 39(12):2309-2318.
14. Kleinfeld AM: Lipid phase fatty acid flip-flop, is it fast enough for cellular transport? Journal of Membrane Biology 2000, 175(2):79-86.
15. Abumrad NA, Park JH, Park CR: Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. Journal of Biological Chemistry 1984, 259(14):8945-8953.
16. Abumrad NA, Perkins RC, Park JH, Park CR: Mechanism of long chain fatty acid permeation in the isolated adipocyte. Journal of Biological Chemistry 1981, 256(17):9183-9191.
17. Sorrentino D, Stump DD, Van Ness K, Simard A, Schwab AJ, Zhou SL, Goresky CA, Berk PD: Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate. American Journal of Physiology 1996, 270(2 Pt 1):G385-92.
18. Storch J, Lechene C, Kleinfeld AM: Direct determination of free fatty acid transport across the adipocyte plasma membrane using quantitative fluorescence microscopy. Journal of Biological Chemistry 1991, 266(21):13473-13476.
19. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.[see comment]. Nature Genetics 1999, 21(1):76-83.
20. Ibrahimi A, Sfeir Z, Magharaie H, Amri EZ, Grimaldi P, Abumrad NA: Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(7):2646-2651.
21. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N: Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukotrienes & Essential Fatty Acids 1997, 57(1):17-21.
22. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N: CD36 antisense expression in 3T3-F442A preadipocytes. Molecular & Cellular Biochemistry 1999, 192(1-2):3-8.
23. Zhang X, Fitzsimmons RL, Cleland LG, Ey PL, Zannettino AC, Farmer EA, Sincock P, Mayrhofer G: CD36/fatty acid translocase in rats: distribution, isolation from hepatocytes, and comparison with the scavenger receptor SR-B1. Laboratory Investigation 2003, 83(3):317-332.
24. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. Journal of Biological Chemistry 1993, 268(24):17665-17668.
25. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL: A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. Journal of Biological Chemistry 1999, 274(27):19055-19062.
26. Schaffer JE, Lodish HF: Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein.[see comment]. Cell 1994, 79(3):427-436.
27. Stahl A, Evans JG, Pattel S, Hirsch D, Lodish HF: Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Developmental Cell 2002, 2(4):477-488.
28. Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, Watson N, Patel S, Kotler M, Raimondi A, Tartaglia LA, Lodish HF: Identification of the major intestinal fatty acid transport protein. Molecular Cell 1999, 4(3):299-308.
29. Goudriaan JR, Tacken PJ, Dahlmans VE, Gijbels MJ, van Dijk KW, Havekes LM, Jong MC: Protection from obesity in mice lacking the VLDL receptor. Arteriosclerosis, Thrombosis & Vascular Biology 2001, 21(9):1488-1493.
30. Ensler K, Mohammadieh M, Broijersen A, Angelin B, Gafvels M: Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells. Biochimica et Biophysica Acta 2002, 1581(1-2):36-48.
31. Gauthier A, Vassiliou G, Benoist F, McPherson R: Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma. Journal of Biological Chemistry 2003, 278(14):11945-11953.
32. Ko KW, Avramoglu RK, McLeod RS, Vukmirica J, Yao Z: The insulin-stimulated cell surface presentation of low density lipoprotein receptor-related protein in 3T3-L1 adipocytes is sensitive to phosphatidylinositide 3-kinase inhibition. Biochemistry 2001, 40(3):752-759.
33. Vassiliou G, Benoist F, Lau P, Kavaslar GN, McPherson R: The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes. Journal of Biological Chemistry 2001, 276(52):48823-48830.
34. Jones NL, Gupta M, Lewis JC: The LDL receptor and LRP are receptors for beta VLDL on pigeon monocyte-derived macrophages. Virchows Archiv 1995, 426(2):189-198.
35. Kuchenhoff A, Harrach B, Robenek H: Beta-VLDL. A naturally occurring ligand for LRP with physiological importance. Annals of the New York Academy of Sciences 1994, 737:465-467.
36. Fuki IV, Iozzo RV, Williams KJ: Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism. Journal of Biological Chemistry 2000, 275(33):25742-25750.
37. Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP, Iozzo RV, Swenson TL, Fisher EA, Williams KJ: The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. Journal of Clinical Investigation 1997, 100(6):1611-1622.
38. Williams KJ, Fuki IV: Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism [see comments]. Curr Opin Lipidol 1997, 8(5):253-262.
39. Nielsen MS, Brejning J, Garcia R, Zhang H, Hayden MR, Vilaro S, Gliemann J: Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans. J Biol Chem 1997, 272(9):5821-5827.
40. Obunike JC, Pillarisetti S, Paka L, Kako Y, Butteri MJ, Ho YY, Wagner WD, Yamada N, Mazzone T, Deckelbaum RJ, Goldberg IJ: The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production. Arteriosclerosis, Thrombosis & Vascular Biology 2000, 20(1):111-118.
41. Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5(1):19-27.
42. Cornelius P, MacDougald OA, Lane MD: Regulation of adipocyte development. Annu Rev Nutr 1994, 14:99-129.
43. Rubin CS, Hirsch A, Fung C, Rosen OM: Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem 1978, 253(20):7570-7578.
44. Bu G, Schwartz AL: RAP, a novel type of ER chaperone. Trends in Cell Biology 1998, 8(7):272-276.
45. Willnow TE: Receptor-associated protein (RAP): a specialized chaperone for endocytic receptors. Biological Chemistry 1998, 379(8-9):1025-1031.
46. Kolset SO, Salmivirta M: Cell surface heparan sulfate proteoglycans and lipoprotein metabolism. Cellular & Molecular Life Sciences 1999, 56(9-10):857-870.
47. Wilsie LC, Orlando RA: The low density lipoprotein receptorrelated protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. Journal of Biological Chemistry 2003, 278(18):15758-15764.
48. Mulder M, Lombardi P, Jansen H, van Berkel TJ, Frants RR, Havekes LM: Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. Journal of Biological Chemistry 1993, 268(13):9369-9375.
49. Obunike JC, Sivaram P, Paka L, Low MG, Goldberg IJ: Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways. J Lipid Res 1996, 37(11):2439-2449.
50. Yano T, Kobori S, Sakai M, Anami Y, Matsumura T, Matsuda H, Kasho M, Shichiri M: Beta-very low density lipoprotein induces triglyceride accumulation through receptor mediated endocytotic pathway in 3T3-L1 adipocytes. Atherosclerosis 1997, 135(1):57-64.
51. Lugemwa FN, Sarkar AK, Esko JD: Unusual beta-D-xylosides that prime glycosaminoglycans in animal cells. Journal of Biological Chemistry 1996, 271(32):19159-19165.
52. Taylor WH, Sinha A, Khan IA, McDaniel ST, Esko JD: Primers of glycosaminoglycan biosynthesis from Peruvian rain forest plants. Journal of Biological Chemistry 1998, 273(35):22260-22266.
53. MacDougald OA, Hwang CS, Fan H, Lane MD: Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(20):9034-9037.
54. Eckel RH, Prasad JE, Kern PA, Marshall S: Insulin regulation of lipoprotein lipase in cultured isolated rat adipocytes. Endocrinology 1984, 114(5):1665-1671.
55. Enerback S, Ohlsson BG, Samuelsson L, Bjursell G: Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis. Molecular & Cellular Biology 1992, 12(10):4622-4633.
56. Hussain MM, Strickland DK, Bakillah A: The mammalian low-density lipoprotein receptor family. Annual Review of Nutrition 1999, 19:141-172.
57. Mahley RW, Ji ZS: Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. Journal of Lipid Research 1999, 40(1):1-16.
58. Ibrahimi A, Abumrad NA: Role of CD36 in membrane transport of long-chain fatty acids. Current Opinion in Clinical Nutrition & Metabolic Care 2002, 5(2):139-145.
59. Kalant D, Cianflone K: Regulation of fatty acid transport. Curr Opin Lipidol 2004, 15:309-314.
60. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry 1999, 68:729-777.
61. Carey DJ: Syndecans: multifunctional cell-surface co-receptors. Biochemical Journal 1997, 327(Pt 1):1-16.
62. Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annual Review of Biochemistry 1998, 67:609-652.
63. Rioux V, Landry RY, Bensadoun A: Sandwich immunoassay for the measurement of murine syndecan-4. J Lipid Res 2002, 43(1):167-173.
64. Elenius K, Maatta A, Salmivirta M, Jalkanen M: Growth factors induce 3T3 cells to express bFGF-binding syndecan. Journal of Biological Chemistry 1992, 267(9):6435-6441.
65. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell JR: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. Journal of Biological Chemistry 1991, 266(34):22939-22947.
66. Murdoch AD, Liu B, Schwarting R, Tuan RS, Iozzo RV: Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. Journal of Histochemistry & Cytochemistry 1994, 42(2):239-249.
67. Misra KB, Kim KC, Cho S, Low MG, Bensadoun A: Purification and characterization of adipocyte heparan sulfate proteoglycans with affinity for lipoprotein lipase. Journal of Biological Chemistry 1994, 269(38):23838-23844.
68. Milici AJ, Watrous NE, Stukenbrok H, Palade GE: Transcytosis of albumin in capillary endothelium. Journal of Cell Biology 1987, 105(6 Pt 1):2603-2612.
69. Predescu SA, Predescu DN, Palade GE: Plasmalemmal vesicles function as transcytotic carriers for small proteins in the continuous endothelium. American Journal of Physiology 1997, 272(2 Pt 2):H937-49.
70. Predescu SA, Predescu DN, Palade GE: Endothelial transcytotic machinery involves supramolecular protein-lipid complexes. Molecular Biology of the Cell 2001, 12(4):1019-1033.
71. Obunike JC, Lutz EP, Li Z, Paka L, Katopodis T, Strickland DK, Kozarsky KF, Pillarisetti S, Goldberg IJ: Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. Journal of Biological Chemistry 2001, 276(12):8934-8941.
72. Chun JT, Wang L, Pasinetti GM, Finch CE, Zlokovic BV: Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Experimental Neurology 1999, 157(1):194-201.
73. Marino M, Zheng G, Chiovato L, Pinchera A, Brown D, Andrews D, McCluskey RT: Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. Journal of Biological Chemistry 2000, 275(10):7125-7137.
74. Czekay RP, Orlando RA, Woodward L, Adamson ED, Farquhar MG: The expression of megalin (gp330) and LRP diverges during F9 cell differentiation. Journal of Cell Science 1995, 108(Pt 4):1433-1441.
75. Czekay RP, Orlando RA, Woodward L, Lundstrom M, Farquhar MG: Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes. Molecular Biology of the Cell 1997, 8(3):517-532.
76. Orlando RA, Farquhar MG: Functional domains of the receptorassociated protein (RAP). Proceedings of the National Academy of Sciences of the United States of America 1994, 91(8):3161-3165.
77. Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA: Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. Journal of Clinical Investigation 1997, 100(9):2303-2309.
78. Goldstein JL, Basu SK, Brown MS: Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods in Enzymology 1983, 98:241-260.